FIELD: medicine, pharmacy. SUBSTANCE: invention relates to pharmaceutical preparations and can be used in treatment of hypercholesterolemia (primary, in combination with hypertriglyceridemia), atherosclerosis. Invention involves the use of lovastatin as active component and microcrystalline cellulose, starch, modified starch or croscarmellose, stearic acid or its salts, butyloxyanisol and lactose as accessory components taken in the definite ratio of components. Invention provides stability of drug in storage for all time of preparation fitness. EFFECT: enhanced effectiveness of agent. 4 cl
Authors
Dates
2002-11-20—Published
2001-07-05—Filed